Is AMI Organics a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that AMI Organics Ltd is a good quality company .

Is AMI Organics undervalued or overvalued?

The key valuation ratios of AMI Organics Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is AMI Organics share price return in the past 10 years?

Data is not available for this company

Is AMI Organics a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of AMI Organics Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

AMI Organics Ltd - Stock Valuation and Financial Performance

Name: AMI Organics
Brand: AMI Organics

BSE: 543349 | NSE: AMIORG | Pharmaceuticals & Drugs | Small Cap

Place order

AMI Organics Share Price

₹1,187.55 -14.30 -1.19%
as on 19-Apr'24 16:01

10 Year X-Ray of AMI Organics:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	18.2%	17.2%	27.1%	23.2%	22.7%	23.4%	20.6%	24.8%	18.7%	15.2%	-
Value Creation Index ⓘ	0.3	0.2	0.9	0.7	0.6	0.7	0.5	0.8	0.3	0.1	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	76.1	112	154	160	188	236	240	341	520	617	654
Sales YoY Gr.	-	46.8%	37.5%	4.3%	17.5%	25.2%	1.7%	42.1%	52.7%	18.6%	-
Adj EPS ⓘ	0.8	1.3	3.5	3.8	5.3	7.7	8.6	5.7	19.7	22.7	10.5
YoY Gr.	-	64.6%	170%	7.7%	40.2%	45.5%	12.1%	-33.7%	244.5%	14.8%	-
BVPS (₹) ⓘ	3.4	4.7	8.7	12.5	18.4	25.8	34.3	17.4	142.2	161	173.9
Adj Net Profit ⓘ	2.5	4.1	11	11.9	16.7	24.3	27.2	54.1	71.9	82.6	39
Cash Flow from Ops. ⓘ	-0.2	-3.9	10.1	28.8	10	21.8	27.3	26.9	-9.7	55.7	-
Debt/CF from Ops. ⓘ	-59.1	-5.9	2.9	0.9	4.4	2.5	2.2	5.1	-0.1	0.1	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	26.2%	26.8%	37%	18.6%
Adj EPS ⓘ	45.2%	33.7%	37.9%	14.8%
BVPSⓘ	53.4%	54.4%	67.5%	13.3%
Share Price	-	-	-	12.4%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	26.2	32	52.2	35.7	34.4	34.9	28.8	39.8	21.1	15	6.3
Op. Profit Mgn % ⓘ	8	7.4	11.8	14.4	16.2	18.2	17.5	23.8	20.2	20.1	16.6
Net Profit Mgn % ⓘ	3.3	3.7	7.2	7.4	8.9	10.3	11.4	15.9	13.8	13.4	5.9
Debt to Equity ⓘ	1.1	1.6	1.1	0.7	0.8	0.7	0.6	0.8	0	0	-
Working Cap Days ⓘ	124	131	137	150	148	164	188	181	195	224	131
Cash Conv. Cycle ⓘ	30	32	38	30	30	36	52	56	72	89	75

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 37.04%

Net Profit is growing at healthy rate in last 3 years 37.91%

Sales growth is good in last 4 quarters at 13.99%

Return on Equity has declined versus last 3 years average to 6.30%

Latest Financials - AMI Organics Ltd.

	Standalone	Consolidated
TTM EPS (₹)	10.5	11.3
TTM Sales (₹ Cr.)	654	668
BVPS (₹.) ⓘ	173.9	175.8
Reserves (₹ Cr.) ⓘ	605	611
P/BV ⓘ	6.91	6.84
PE ⓘ	114.35	106.16

From the Market
52 Week Low / High (₹)	1005.05 / 1387.50
All Time Low / High (₹)	764.15 / 1438.50
Market Cap (₹ Cr.)	4,432
Equity (₹ Cr.)	36.9
Face Value (₹)	10
Industry PE ⓘ	47.6

Management X-Ray of AMI Organics:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of AMI Organics

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of AMI Organics

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	76	112	154	160	188	236	240	341	520	617
Operating Expenses ⓘ	70	103	136	137	158	193	199	260	415	494
Manufacturing Costs	7	9	16	16	21	21	39	46	71	69
Material Costs	47	67	91	95	113	149	129	180	273	331
Employee Cost	4	4	7	7	10	11	18	21	41	49
Other Costs ⓘ	12	23	21	18	14	11	13	14	30	45
Operating Profit ⓘ	6	8	18	23	31	43	41	80	105	123
Operating Profit Margin (%)	8.0%	7.4%	11.8%	14.4%	16.2%	18.2%	17.1%	23.5%	20.2%	19.9%
Other Income ⓘ	1	0	3	0	3	1	3	1	3	4
Interest ⓘ	2	2	3	3	3	5	6	6	6	2
Depreciation ⓘ	1	1	1	1	2	3	4	4	10	12
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	4	6	18	19	28	37	35	72	91	112
Tax ⓘ	1	2	5	7	10	12	7	18	20	29
Profit After Tax	3	4	13	12	18	25	27	54	72	83
PAT Margin (%)	3.8%	3.7%	8.2%	7.5%	9.8%	10.5%	11.5%	15.9%	13.8%	13.5%
Adjusted EPS (₹)	0.9	1.3	4.0	3.8	5.9	7.8	8.7	5.7	19.8	22.9
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	15%	13%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	11	15	27	39	58	81	108	164	518	587
Share Capital ⓘ	2	2	2	2	2	11	11	32	36	36
Reserves ⓘ	9	13	26	38	56	71	97	132	482	550
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	10	21	27	23	41	48	54	117	1	3
Long Term Debt	1	6	16	14	31	22	20	73	1	0
Short Term Debt	9	14	11	9	9	26	34	45	0	3
Trade Payables	15	20	28	38	48	69	51	85	118	142
Others Liabilities ⓘ	3	3	8	8	9	14	15	44	18	28
Total Liabilities ⓘ	38	59	91	109	155	212	228	410	655	759
Fixed Assets
Gross Block	10	11	15	22	24	70	75	177	204	261
Accumulated Depreciation	5	6	6	8	10	12	13	17	27	39
Net Fixed Assetsⓘ	5	6	9	15	15	58	62	161	178	222
CWIP ⓘ	2	4	4	11	30	2	12	0	3	30
Investmentsⓘ	0	0	11	15	21	28	28	33	33	33
Inventories	11	14	20	20	27	39	52	60	112	119
Trade Receivables	14	24	36	36	50	73	53	119	162	230
Cash Equivalents	0	1	1	3	1	0	3	2	99	59
Others Assetsⓘ	7	10	11	8	11	12	18	36	68	66
Total Assets ⓘ	38	59	91	109	155	212	228	410	655	759

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	0	-4	10	29	10	22	27	27	-10	56
PBT ⓘ	4	6	18	19	28	37	35	72	91	112
Adjustment ⓘ	2	2	3	4	4	5	7	9	12	11
Changes in Working Capital ⓘ	-5	-11	-7	13	-15	-6	-7	-40	-91	-43
Tax Paid ⓘ	-1	-1	-3	-7	-8	-14	-8	-14	-23	-24
Cash Flow From Investing Activity ⓘ	-2	-4	-14	-19	-27	-25	-24	-101	-122	-20
Capex	-2	-4	-3	-15	-21	-17	-19	-102	-33	-84
Net Investments	0	0	-11	-4	-6	-8	-5	1	-92	61
Others ⓘ	0	0	0	0	0	0	0	0	3	2
Cash Flow From Financing Activityⓘ	2	9	4	-7	14	3	0	72	140	-14
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	300	0
Net Proceeds from Borrowing ⓘ	0	5	10	-1	17	-9	0	0	-136	2
Interest Paid ⓘ	-2	-2	-2	-3	-3	-4	-5	-5	-5	-2
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	-11
Others ⓘ	4	5	-3	-2	0	17	6	77	-18	-3
Net Cash Flow ⓘ	0	0	0	2	-2	0	3	-2	8	21

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	30.26	31.99	59.83	36.07	37.94	35.45	29.06	39.72	21.1	15.09
ROCE (%)	29.97	25.03	42.73	35.8	37.76	35.02	26.68	33.05	23.88	20.67
Asset Turnover Ratio	2.35	2.3	2.05	1.6	1.42	1.28	1.09	1.07	0.98	0.87
PAT to CFO Conversion(x)	0	-1	0.77	2.42	0.56	0.88	1	0.5	-0.14	0.67
Working Capital Days
Receivable Days	58	62	72	83	84	95	95	92	98	116
Inventory Days	42	41	40	45	46	51	69	60	61	68
Payable Days	91	94	97	128	139	142	170	138	136	144

AMI Organics Ltd Stock News

AMI Organics Ltd FAQs

What is the share price of AMI Organics?

Company share prices are keep on changing according to the market conditions. The closing price of AMI Organics on 19-Apr-2024 16:01 is ₹1,187.6.

What is the market cap of AMI Organics?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 19-Apr-2024 16:01 the market cap of AMI Organics stood at ₹4,432.5.

What is the P/E ratio of AMI Organics?

The latest P/E ratio of AMI Organics as of 19-Apr-2024 16:01 is 114.3.

What is the P/B ratio of AMI Organics?

The latest P/B ratio of AMI Organics as of 19-Apr-2024 16:01 is 6.91.

What is the 52-week high and low of AMI Organics?

The 52-week high of AMI Organics is ₹1,387.5 and the 52-week low is ₹1,005.1.

What is the TTM revenue of AMI Organics?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of AMI Organics is ₹654.0 ( Cr.) .

About AMI Organics Ltd

Ami Organics is a research and development (R&D) driven manufacturer of specialty chemicals with varied end usage, focused towards the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates) for regulated and generic active pharmaceutical ingredients (APIs) and New Chemical Entities (NCE) and key starting material for agrochemical and fine chemicals, especially from its recent acquisition of the business of Gujarat Organics (GOL) (Acquisition). The company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban. The Pharma Intermediates which it manufacture, find application in certain high-growth therapeutic areas including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant, commanding significant market share both in India and globally.

The company has developed and commercialized over 450 Pharma Intermediates for APIs across 17 key therapeutic areas since inception and NCE, with a strong focus on R&D across select high-growth high margin therapeutic areas such as anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant, for use across the global pharmaceutical market. In addition, the company recently completed the acquisition of two additional manufacturing facilities operated by GOL which has added preservatives (parabens and parabens formulations which have end usage in cosmetics, animal food and personal care industries) and other specialty chemicals (with end usage in inter alia the cosmetics, dyes polymers and agrochemicals industries) in its existing product portfolio, which command significant market share globally in the supply of certain paraben derivatives. The acquisition is in line with company’s inorganic growth strategy of foraying further into the specialty chemicals sector and it will enable it to significantly diversify its existing product portfolio, with an objective of attaining inorganic expansion of its business.

Business area of the company

The company is one of the leading research and development driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical ingredients (API) for New Chemical Entities, and material for agrochemicals and fine chemicals.

Awards, accreditations or recognitions

2005: Gujarat Gas Safety Award for developing and implementing effective HSE Management System by Gujarat Gas Company Limited.
2016: Obtained certifications for ISO 9001:2015 and ISO 14001:2015.
2017: Outstanding export performance “Second Award” under the category of Panel - II: Inorganic, Organic and Agro Chemicals - (SSM) for the year 2016-17.
2018: Conferred the title of the “Best Recuiter” by Uka Tarsadia University, Bardoli.
2018: Recognition by the Directorate General of Foreign Trade with status of ‘Two Star Export House’.
2018: Certified by the Central Board of Indirect Taxes and Customs as ‘Authorised Economic Operator’ in recognition and appreciation of Company’s commitment to secure international supply chain and compliance with ‘WCO’s SAFE Framework of Standards’.
2018: Obtained certification for SA 8000:2014.
2018: “Business Innovation Award” under Dare to Dream awards by SAP.
2019: Obtained certification for ISO 45001:2018.
2021: Award for Excellence in the ‘Research in Science & Technology’ category by the Federation of Gujarat Industries.
2021: Fairdeal Filaments Awards for Outstanding Entrepreneur in MSME Segment by the Southern Gujarat Chamber of Commerce & Industry.

Major events and milestones

2004: Formation of partnership firm in the name of “Ami Organics”.
2007: Ami Organics changed its constitution into Ami Organics Private Limited.
2011: Implemented the Integrated Management System (IMS).
2015: Achieved turnover of Rs 1,000 million.
2015: Incorporated Ami Onco-Theranostics, LLC in USA along with Photolitec LLC.
2016: Established a tertiary effluent treatment plant to become zero liquid discharge plant.
2016: Received recognition from the Department of Scientific and Industrial Research for company's in-house research and development (R&D) unit.
2017: Increased warehouse capacity by establishing a warehouse equipped with modern infrastructure including fire and safety and having a storage capacity of 1050 metric ton (MT) of raw material.
2017: Achieved turnover of Rs 1,500 million.
2017: Applied for process patents for five products in India.
2018: Completed assessment of and established a good manufacturing practice (GMP) compliant facility at company’s production site and warehouse in Surat, Gujarat.
2018: Applied for process patents for three additional products in India.
2018: Converted Ami Organics Private Limited into a public limited company, Ami Organics Limited.
2018: Received first establishment inspection report (“EIR”) from the United States Food and Drug Administration (“USFDA”).
2020: Received second EIR from USFDA for the manufacturing facility at Surat, Gujarat.
2020: Commencement of a new research and development laboratory at Sachin, Surat, Gujarat.
2020: Commencement of the new solvent recovery plant at Sachin, Surat, Gujarat.
2021: Acquisition of the Ankleshwar and Jhagadia units from Gujarat Organics Limited.
2021: Applied for process patents for three additional products in India.